Last updated: April 25, 2026
Firmagon (degarelix) Suppliers: Who Provides the Inputs
Firmagon is a brand of degarelix (a GnRH receptor antagonist). Supplier identification at the “vendor of record” level is typically documented in regulatory chemistry and manufacturing (CMC) filings and procurement disclosures, not in consumer-facing materials. Without access to those filings and contracting records, a complete, source-verified supplier list cannot be produced.
Because your request is for suppliers, not general manufacturing parties, and the dataset needed to name specific vendors cannot be verified from the information available here, no supplier list can be provided without risking incorrect attribution.
What can be stated from public facts
1) Who manufacturers Firmagon
Firmagon is marketed by Ferring Pharmaceuticals (Ferring’s site and product materials identify the brand and market authorization holder, depending on territory).
- Brand owner / marketing authorization holder (typical role): Ferring Pharmaceuticals (degarelix product line)
2) Active ingredient and product supply
Degarelix is an injectable drug product. In practice, supplies split into:
- API production (degarelix bulk drug substance)
- Drug product manufacturing (final sterile formulation and fill-finish)
Public sources often name the brand owner and sometimes the manufacturing site, but do not consistently name upstream API suppliers or component vendors. Firmagon-specific “supplier of X” detail requires CMC or tender documentation by territory.
3) Regulatory documentation is the controlling source
The only reliable way to name “suppliers” for Firmagon inputs is through:
- EMA / national CMC assessment reports (when accessible)
- EPAR / assessment documentation (where sites are listed)
- FDA Orange Book and related CMC references (where applicable)
- DMFs and letters of access (when publicly indexed)
Those documents determine:
- Drug substance manufacturer(s)
- Drug product manufacturer(s)
- Sterile manufacturing and packaging sites
Supplier mapping framework (for Firmagon)
Use this structure to compile a source-verified supplier list from regulatory and procurement artifacts:
| Input category |
What to capture |
What regulatory artifacts usually show |
| API (degarelix) |
API manufacturer name and site(s) |
Drug substance section in CMC / DMF references |
| Sterile drug product |
Final manufacturing site(s) |
Drug product section in CMC / EPAR labeling |
| Fill-finish |
Sterile filling/lyophilization/packaging vendor site(s) |
Manufacturing and control section, site references |
| Finished packaging |
Primary and secondary packaging suppliers |
Packaging section in CMC and label annexes |
| Supply chain critical materials |
Key raw materials and excipients vendor(s) |
Not consistently public; may appear in CMC or inspections |
Key Takeaways
- A verifiable supplier list for Firmagon inputs cannot be produced without access to territory-specific CMC/EPAR and/or DMF/inspection and procurement records.
- Ferring Pharmaceuticals is the established brand marketer/authorization holder for Firmagon, but this does not equate to naming API or component suppliers.
- For accurate supplier identification, the controlling evidence is CMC/regulatory documentation that lists drug substance and drug product manufacturing sites.
FAQs
1) Who supplies Firmagon to the market?
Firmagon is marketed by Ferring Pharmaceuticals, with supply executed through its manufacturing and distribution network by territory.
2) Who makes the degarelix active ingredient?
The degarelix API maker must be identified from Firmagon CMC drug substance documentation or DMF-linked references for the relevant jurisdiction and product version.
3) Who manufactures the sterile injection and fill-finish?
The drug product manufacturer and sterile fill-finish sites must be verified from Firmagon drug product CMC/assessment documentation by territory.
4) Are excipient and packaging suppliers publicly listed?
Not consistently. Packaging and excipient vendors may appear in CMC, but public summaries often omit upstream supplier names.
5) What is the fastest way to build an authoritative supplier list?
Compile names directly from regulatory CMC assessment documentation for each jurisdiction and product presentation, then cross-check with site-level manufacturing authorizations.
References
[1] Ferring Pharmaceuticals. Firmagon (degarelix) product information and company materials (brand marketing/authorization holder context).
